[Cryoprecipitate should have preference over factor VIII concentrate in the treatment of patients with hemophilia A].
Kunst
V A
VA
Nováková
I R
IR
Haanen
C
C
D000163:Acquired Immunodeficiency Syndrome / Q000635:transmission; D003365:Costs and Cost Analysis; D005169:Factor VIII / Q000009:adverse effects / Q000302:isolation & purification* / Q000627:therapeutic use; D006467:Hemophilia A / Q000191:economics / Q000628:therapy*; D006801:Humans; D012307:Risk Factors
D005169:Factor VIII
Cryoprecipitaat verdient de voorkeur boven factor VIII-concentraat bij de behandeling van patiënten met hemofilie A.